Latest 10-K annual reports

Soluna reported lower 2025 revenue and a wider net loss but ended the year with $76.4M cash, secured new project financing, advanced key data centers, and added a $250M equity facility in March 2026.

AIM ImmunoTech's 2025 annual report highlights a strategic pivot to late-stage pancreatic cancer for Ampligen, despite ongoing financial losses and NYSE American delisting concerns.

Space Asset Acquisition Corp. (SAAQ) filed its annual 10-K, outlining its blank check company structure, IPO details, and strategy to acquire a business in the global space economy.

Immix Biopharma, Inc. filed an amendment to its 2025 Annual Report on Form 10-K, primarily to correct the auditor report date, while revealing significant capital raises and increased liquidity despite growing net losses.

Gesher Acquisition Corp. II, a SPAC, reported a net income of $3.47 million for 2025, driven by interest income, but faces substantial doubt about its ability to continue as a going concern without completing a business combination by December 2026.

K&F Growth Acquisition Corp. II, a SPAC, reported a net income of $10.2 million for 2025, primarily from trust account interest, but faces substantial doubt about its ability to continue as a going concern without a business combination by November 2026.

Enveric Biosciences, a biotechnology company, reported substantial doubt about its ability to continue as a going concern despite recent capital raises, as it focuses on preclinical development of its lead neuroplastogen candidate, EB-003.

SKYX Platforms Corp. filed an amended annual report for fiscal year 2025, primarily to correct an auditor report date, while highlighting ongoing liquidity challenges and recent capital raises.

Fusemachines Inc. reported a significantly reduced net loss for 2025 following a business combination, but faces a Nasdaq listing compliance issue and ongoing going concern doubts.

Utah Medical Products Inc. reported a decline in 2025 revenues and net income, impacted by lost OEM sales and Filshie Clip litigation, despite maintaining strong cash reserves.

DICK'S Sporting Goods reports a 28.1% net sales increase to $17.22 billion in fiscal 2025, driven by the Foot Locker acquisition and 4.5% comparable sales growth in its core business, despite a significant drop in net income due to acquisition-related costs.

Air Industries Group reported a net loss of $1.3 million in 2025, faces substantial doubt about its ability to continue as a going concern, and plans a highly dilutive merger with Tenax Aerospace Acquisition.

Spartacus Acquisition Corp. II, a SPAC, outlines its post-IPO structure, financial position, and search for a business combination in the TMT sector.

Daedalus Special Acquisition Corp. successfully completed its $250 million IPO and private placement, positioning itself to acquire a leading consumer AI company.

SIM Acquisition Corp. I reports a strategic pivot to U.S. industrial and tech sectors, new leadership, and a fee reduction agreement, while acknowledging substantial doubt about its ability to continue as a going concern.

Knightscope, a security technology firm, reported a 5% revenue increase to $11.3 million in 2025, alongside a widened net loss of $33.8 million, while completing a significant acquisition to bolster its integrated security platform.

Tenon Medical, Inc. reported increased revenue for 2025 but continues to face significant operating losses, a going concern doubt, and a Nasdaq delisting notice due to its low bid price.

Crown Reserve Acquisition Corp. I, a SPAC, reported a net income of $1.13 million for 2025, primarily from trust account dividends, as it continues its search for a business combination.

Launchpad Cadenza Acquisition Corp I filed its annual 10-K report, outlining its SPAC structure, IPO details, target industries, and the ongoing search for a business combination.

Abony Acquisition Corp. I's 10-K filing outlines its blank check company structure, recent IPO, and plans to pursue a business combination in defense tech, advanced computing, software, and media sectors.

Functional Brands Inc. reports a Nasdaq listing, new health platform launch, but faces delisting risk and internal control weaknesses.

1606 Corp. pivots from AI chatbots to power infrastructure and data centers, announcing a major Texas acquisition while grappling with significant financing challenges and a going concern warning.

SPACSphere Acquisition Corp. filed its 10-K, detailing its recent $172.5 million IPO, private placement, and ongoing search for a business combination target by May 2027.

PAVmed Inc. reports significant financial restructuring, including a reverse stock split and capital raises, while advancing its medical device and diagnostics portfolio amidst ongoing operating losses.

Soulpower Acquisition Corp. files its annual 10-K, outlining its proposed business combination with SWB LLC to form Soul World Bank and detailing its financial position as a SPAC.

Presidio Property Trust reports significant asset dispositions, a reverse stock split, and the suspension of Series D Preferred Stock dividends amidst substantial property impairments and a net loss for 2025.

BioXcel Therapeutics reported significant operating losses and declining product revenue for 2025, raising substantial doubt about its ability to continue as a going concern, despite positive clinical trial data for IGALMI's at-home use and ongoing capital raises.

Alussa Energy Acquisition Corp. II, a blank check company, filed its annual 10-K report for 2025, detailing its initial public offering, financial position, and ongoing search for a business combination in the energy sector.

Calidi Biotherapeutics reported significant losses and expressed substantial doubt about its ability to continue as a going concern, despite advancing its RedTail platform and securing recent financings.

Manhattan Bridge Capital reported a decrease in 2025 net income and revenue, while successfully extending key credit facilities and continuing its share repurchase program.